Diabetes Self-Management – FDA Panel Votes in Favor of Inhalable Insulin; Diet Drug Recalled

On March 27, pharmaceutical manufacturer GlaxoSmithKline (GSK) Consumer Healthcare voluntarily recalled all nonprescription supplies of the weight-loss drug alli (generic name orlistat) from retailers in the United States and Puerto Rico due to tampering concerns. Read more



from DiabetesNews http://ift.tt/1hqIfPt